Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74899833 | 7489983 | 3 | F | 20080829 | 20160823 | 20100719 | 20160823 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-14136378 | BRISTOL MYERS SQUIBB | 35.64 | YR | F | Y | 65.00000 | KG | 20160823 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74899833 | 7489983 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, UNK | 21436 | 30 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 74899833 | 7489983 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 74899833 | 7489983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 74899833 | 7489983 | Drug abuse | |
| 74899833 | 7489983 | Live birth | |
| 74899833 | 7489983 | Maternal exposure during pregnancy | |
| 74899833 | 7489983 | Stress | |
| 74899833 | 7489983 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 74899833 | 7489983 | 1 | 200709 | 0 |